Cargando…

Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals

BACKGROUND: Invasive Escherichia coli disease (IED), including bloodstream infection, sepsis, and septic shock, can lead to high hospitalization and mortality rates. This multinational study describes the clinical profile of patients with IED in tertiary care hospitals. METHODS: We applied clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Doua, Joachim, Geurtsen, Jeroen, Rodriguez-Baño, Jesus, Cornely, Oliver A, Go, Oscar, Gomila-Grange, Aina, Kirby, Andrew, Hermans, Peter, Gori, Andrea, Zuccaro, Valentina, Gravenstein, Stefan, Bonten, Marc, Poolman, Jan, Sarnecki, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933942/
https://www.ncbi.nlm.nih.gov/pubmed/36817744
http://dx.doi.org/10.1093/ofid/ofad026
_version_ 1784889775345369088
author Doua, Joachim
Geurtsen, Jeroen
Rodriguez-Baño, Jesus
Cornely, Oliver A
Go, Oscar
Gomila-Grange, Aina
Kirby, Andrew
Hermans, Peter
Gori, Andrea
Zuccaro, Valentina
Gravenstein, Stefan
Bonten, Marc
Poolman, Jan
Sarnecki, Michal
author_facet Doua, Joachim
Geurtsen, Jeroen
Rodriguez-Baño, Jesus
Cornely, Oliver A
Go, Oscar
Gomila-Grange, Aina
Kirby, Andrew
Hermans, Peter
Gori, Andrea
Zuccaro, Valentina
Gravenstein, Stefan
Bonten, Marc
Poolman, Jan
Sarnecki, Michal
author_sort Doua, Joachim
collection PubMed
description BACKGROUND: Invasive Escherichia coli disease (IED), including bloodstream infection, sepsis, and septic shock, can lead to high hospitalization and mortality rates. This multinational study describes the clinical profile of patients with IED in tertiary care hospitals. METHODS: We applied clinical criteria of systemic inflammatory response syndrome (SIRS), sepsis, or septic shock to patients hospitalized with culture-confirmed E coli from urine or a presumed sterile site. We assessed a proposed clinical case definition against physician diagnoses. RESULTS: Most patients with IED (N = 902) were adults aged ≥60 years (76.5%); 51.9%, 25.1%, and 23.0% of cases were community-acquired (CA), hospital-acquired (HA), and healthcare-associated (HCA), respectively. The urinary tract was the most common source of infection (52.3%). Systemic inflammatory response syndrome, sepsis, and septic shock were identified in 77.4%, 65.3%, and 14.1% of patients, respectively. Patients >60 years were more likely to exhibit organ dysfunction than those ≤60 years; this trend was not observed for SIRS. The case-fatality rate (CFR) was 20.0% (60–75 years, 21.5%; ≥75 years, 22.2%), with an increase across IED acquisition settings (HA, 28.3%; HCA, 21.7%; CA, 15.2%). Noticeably, 77.8% of patients initiated antibiotic use on the day of culture sample collection. A total of 65.6% and 40.8% of E coli isolates were resistant to ≥1 agent in ≥1 or ≥2 drug class(es). A 96.1% agreement was seen between the proposed clinical case definition and physician's diagnoses of IED. CONCLUSIONS: This study contributes valuable, real-world data about IED severity. An accepted case definition could promote timely and accurate diagnosis of IED and inform the development of novel preventative strategies.
format Online
Article
Text
id pubmed-9933942
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99339422023-02-17 Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals Doua, Joachim Geurtsen, Jeroen Rodriguez-Baño, Jesus Cornely, Oliver A Go, Oscar Gomila-Grange, Aina Kirby, Andrew Hermans, Peter Gori, Andrea Zuccaro, Valentina Gravenstein, Stefan Bonten, Marc Poolman, Jan Sarnecki, Michal Open Forum Infect Dis Major Article BACKGROUND: Invasive Escherichia coli disease (IED), including bloodstream infection, sepsis, and septic shock, can lead to high hospitalization and mortality rates. This multinational study describes the clinical profile of patients with IED in tertiary care hospitals. METHODS: We applied clinical criteria of systemic inflammatory response syndrome (SIRS), sepsis, or septic shock to patients hospitalized with culture-confirmed E coli from urine or a presumed sterile site. We assessed a proposed clinical case definition against physician diagnoses. RESULTS: Most patients with IED (N = 902) were adults aged ≥60 years (76.5%); 51.9%, 25.1%, and 23.0% of cases were community-acquired (CA), hospital-acquired (HA), and healthcare-associated (HCA), respectively. The urinary tract was the most common source of infection (52.3%). Systemic inflammatory response syndrome, sepsis, and septic shock were identified in 77.4%, 65.3%, and 14.1% of patients, respectively. Patients >60 years were more likely to exhibit organ dysfunction than those ≤60 years; this trend was not observed for SIRS. The case-fatality rate (CFR) was 20.0% (60–75 years, 21.5%; ≥75 years, 22.2%), with an increase across IED acquisition settings (HA, 28.3%; HCA, 21.7%; CA, 15.2%). Noticeably, 77.8% of patients initiated antibiotic use on the day of culture sample collection. A total of 65.6% and 40.8% of E coli isolates were resistant to ≥1 agent in ≥1 or ≥2 drug class(es). A 96.1% agreement was seen between the proposed clinical case definition and physician's diagnoses of IED. CONCLUSIONS: This study contributes valuable, real-world data about IED severity. An accepted case definition could promote timely and accurate diagnosis of IED and inform the development of novel preventative strategies. Oxford University Press 2023-01-27 /pmc/articles/PMC9933942/ /pubmed/36817744 http://dx.doi.org/10.1093/ofid/ofad026 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Doua, Joachim
Geurtsen, Jeroen
Rodriguez-Baño, Jesus
Cornely, Oliver A
Go, Oscar
Gomila-Grange, Aina
Kirby, Andrew
Hermans, Peter
Gori, Andrea
Zuccaro, Valentina
Gravenstein, Stefan
Bonten, Marc
Poolman, Jan
Sarnecki, Michal
Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title_full Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title_fullStr Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title_full_unstemmed Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title_short Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals
title_sort epidemiology, clinical features, and antimicrobial resistance of invasive escherichia coli disease in patients admitted in tertiary care hospitals
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933942/
https://www.ncbi.nlm.nih.gov/pubmed/36817744
http://dx.doi.org/10.1093/ofid/ofad026
work_keys_str_mv AT douajoachim epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT geurtsenjeroen epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT rodriguezbanojesus epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT cornelyolivera epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT gooscar epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT gomilagrangeaina epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT kirbyandrew epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT hermanspeter epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT goriandrea epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT zuccarovalentina epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT gravensteinstefan epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT bontenmarc epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT poolmanjan epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals
AT sarneckimichal epidemiologyclinicalfeaturesandantimicrobialresistanceofinvasiveescherichiacolidiseaseinpatientsadmittedintertiarycarehospitals